ational randomised trial of hormone replacement therapy (HRT) in women with a history of early stage breast cancer
Not Applicable
Completed
- Conditions
- BreastCancer
- Registration Number
- ISRCTN29941643
- Lead Sponsor
- Individual Sponsor (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 3000
Inclusion Criteria
1. Patients must have had proven stage I/II breast cancer with no clinical evidence of recurrence since diagnosis
2. Have been given a patient information pack
3. Be postmenopausal as defined by:
a. Having been amenorrhoeic for at least 6 months (including women who have had radiation or chemical induced ovarian suppression) irrespective of menopausal status at time of diagnosis
b. Having received surgical bilateral oophorectomy
c. Be experiencing vasomotor symptoms (i.e. hot flushes or night sweats) with or without vaginal dryness.
All such women are eligible irrespective of current/previous treatment for breast cancer.
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration